@FierceBiotech: Analyst Schoenebaum offers best-case scenario for Axovant's 4-time Alzheimer's loser. More | Follow @FierceBiotech
@JohnCFierce: The dog that didn't bark? Odd that $AXON trolls haven't been on my tail. Where are the die-hard fanatics? Is this mostly an insiders' game? | Follow @JohnCFierce
> The FDA has agreed to review Pfizer's ($PFE) once-daily formulation of Xeljanz for rheumatoid arthritis. Release
> Boston-based Akcea Therapeutics, a subsidiary of Isis ($ISIS), has received an orphan drug designation for volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with rare cases of Familial Chylomicronemia Syndrome. Release
Medical Device News
@FierceMedDev: ICYMI: Quest and Quintiles rev up new lab testing JV. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: Greek referendum: Next big deadline is payment to ECB (assuming no bank run). Sad & ironic that technocrats still have to make this decision. | Follow @VarunSaxena2
@EmilyWFierce: A Perfect Blood Test For Pancreatic Cancer? Forbes story | Follow @EmilyWFierce
> Report: Despite growth in the device industry, effective concussion treatment remains elusive. More
> Allergan to buy dry eye device startup Oculeve for $125M+. News
Pharma News
@FiercePharma: USDA amends rules to allow vets to make custom vaccines in their offices. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: Don't miss our July 8 Twitter chat on sustained release with BASF expert Thorsten Cech. Details are here | Follow @EricPFierce
@CarlyHFierce: ICYMI from FiercePharmaMarketing: Bayer draws up big sales plans for ex-Merck OTC meds. Story | Follow @CarlyHFierce
> Hospira's Remicade biosimilar wins large French contract with deep discount. More
> Sanofi and Gilead set sail to Japan with new approvals for Toujeo, Harvoni. Article
Pharma Marketing News
> Hot summer ad wars: Celgene launches Otezla DTC into crowded psoriasis drug market. More
> Sanofi, Regeneron break out the popcorn for cholesterol-fighting, PCSK9-friendly documentary. Story
> Expecting payer pushback, Vertex to field new CF med Orkambi at $259K. Article
> Dry-eye expert Allergan bets $125M on Oculeve and its new implant approach. Item
> Hotel workers lobby to stop Big Pharma funding for CME. More
Animal Health News
> Flu season over? Not for dogs. Item
> Patterson offloads medical unit to private equity firm for $715M, boosts focus on animal health. Report
> Report: With Valeant takeover rumors fading, could Zoetis buy IDEXX? More
> USDA amends rules to allow vets to make custom vaccines in their offices. Story
> FDA, Gates Foundation call for improved global access to veterinary drugs. Article
Biotech IT News
> Broad Institute snaps up GemCode Platform as 10X Genomics starts shipping. News
> Novartis steps into wearables with app for Apple Watch, Android Wear. More
> Mousera bags $20M VC round to advance sensor tech in preclinical research. Story
> BioClinica mounts European expansion to push imaging and eClinical. Article
> Congressman pushes to unshackle pharma on social media. Report